| 1. |
Kovvuru K, Velez JCQ. Complications associated with continuous renal replacement therapy. Semin Dial, 2021, 34(6): 489-494.
|
| 2. |
Takeda E, Taketani Y, Sawada N, et al. The regulation and function of phosphate in the human body. Biofactors, 2004, 21(1/2/3/4): 345-355.
|
| 3. |
Yang Y, Zhang P, Cui Y, et al. Hypophosphatemia during continuous veno-venous hemofiltration is associated with mortality in critically ill patients with acute kidney injury. Crit Care, 2013, 17(5): R205.
|
| 4. |
Demirjian S, Teo BW, Guzman JA, et al. Hypophosphatemia during continuous hemodialysis is associated with prolonged respiratory failure in patients with acute kidney injury. Nephrol Dial Transplant, 2011, 26(11): 3508-3514.
|
| 5. |
Lim C, Tan HK, Kaushik M. Hypophosphatemia in critically ill patients with acute kidney injury treated with hemodialysis is associated with adverse events. Clin Kidney J, 2017, 10(3): 341-347.
|
| 6. |
张瑞, 石松菁. 低磷血症对危重症患者影响的研究进展. 创伤与急诊电子杂志, 2015, 3(1): 1-3, 15.
|
| 7. |
Crook M, Swaminathan R. Disorders of plasma phosphate and indications for its measurement. Ann Clin Biochem, 1996, 33(Pt 5): 376-396.
|
| 8. |
Manghat P, Sodi R, Swaminathan R. Phosphate homeostasis and disorders. Ann Clin Biochem, 2014, 51(Pt 6): 631-656.
|
| 9. |
Bergwitz C, Jüppner H. Regulation of phosphate homeostasis by PTH, vitamin D, and FGF23. Annu Rev Med, 2010, 61: 91-104.
|
| 10. |
Fall P, Szerlip HM. Continuous renal replacement therapy: cause and treatment of electrolyte complications. Semin Dial, 2010, 23(6): 581-585.
|
| 11. |
门莉, 王绍锋. 慢性阻塞性肺疾病患者并发低磷血症 105 例分析. 实用临床医学, 2003, 4(6): 84.
|
| 12. |
Hendrix RJ, Hastings MC, Samarin M, et al. Predictors of hypophosphatemia and outcomes during continuous renal replacement therapy. Blood Purif, 2020, 49(6): 700-707.
|
| 13. |
Kim SY, Kim YN, Shin HS, et al. The influence of hypophosphatemia on outcomes of low- and high-intensity continuous renal replacement therapy in critically ill patients with acute kidney injury. Kidney Res Clin Pract, 2017, 36(3): 240-249.
|
| 14. |
孙汀, 任玉倩, 王斐, 等. 危重症患儿连续性血液净化与低磷血症的相关性分析. 中华儿科杂志, 2018, 56(4): 284-288.
|
| 15. |
Heung M, Mueller BA. Prevention of hypophosphatemia during continuous renal replacement therapy-an overlooked problem. Semin Dial, 2018, 31(3): 213-218.
|
| 16. |
Geerse DA, Bindels AJ, Kuiper MA, et al. Treatment of hypophosphatemia in the intensive care unit: a review. Crit Care, 2010, 14(4): R147.
|
| 17. |
Song YH, Seo EH, Yoo YS, et al. Phosphate supplementation for hypophosphatemia during continuous renal replacement therapy in adults. Ren Fail, 2019, 41(1): 72-79.
|
| 18. |
Santiago MJ, López-Herce J, Urbano J, et al. Hypophosphatemia and phosphate supplementation during continuous renal replacement therapy in children. Kidney Int, 2009, 75(3): 312-316.
|
| 19. |
Broman M, Carlsson O, Friberg H, et al. Phosphate-containing dialysis solution prevents hypophosphatemia during continuous renal replacement therapy. Acta Anaesthesiol Scand, 2011, 55(1): 39-45.
|
| 20. |
Godaly G, Carlsson O, Broman M. Phoxilium(®) reduces hypophosphataemia and magnesium supplementation during continuous renal replacement therapy. Clin Kidney J, 2016, 9(2): 205-210.
|
| 21. |
Pistolesi V, Zeppilli L, Fiaccadori E, et al. Hypophosphatemia in critically ill patients with acute kidney injury on renal replacement therapies. J Nephrol, 2019, 32(6): 895-908.
|
| 22. |
Chua HR, Schneider AG, Baldwin I, et al. Phoxilium vs Hemosol-B0 for continuous renal replacement therapy in acute kidney injury. J Crit Care, 2013, 28(5): 884.e7-14.
|
| 23. |
Thompson Bastin ML, Adams PM, Nerusu S, et al. Association of phosphate containing solutions with incident hypophosphatemia in critically ill patients requiring continuous renal replacement therapy. Blood Purif, 2022, 51(2): 122-129.
|
| 24. |
Kim DW, Kim HJ, Kim JM, et al. Effect of Phoxilium on prognostic predictors in patients undergoing continuous venovenous hemodiafiltration. Kidney Res Clin Pract, 2021, 40(3): 457-471.
|
